Announcements Trials

Browse Landscape

Phase

Phase 2 7 Phase NA 1 Phase 4 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Rectal Neoplasms 2 Hodgkin Disease 2 Breast Neoplasms 2 Anemia 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1

Interventions

Gemcitabine 2 Etoposide 2 Cisplatin 2 ruxolitinib 1 pegaspargase 1 Radiotherapy 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lenalidomide 1 Drug Therapy 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoma, Extranodal NK-T-Cell × Radiotherapy × Clear all

NCT01501136 2015-07-17

CTTNKTL-I/II

Zhengzhou University

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡